The COVID-19 Coronavirus and Influenza A/B Virus Real Time PCR Kit: What Buyers Can Verify

COVID-19 Coronavirus and Influenza A/B Virus Real Time PCR Kit

Labs often need respiratory testing capacity that can cover multiple targets within one workflow. This Bioperfectus kit is listed for molecular diagnostic testing related to COVID-19 Coronavirus and Influenza A/B Virus.

The catalog entry identifies JC10310-1NW and package sizes of 25 or 50 tests per kit. Those configurations matter for labs comparing run frequency, storage, and waste against expected demand.

The product page states CE-IVD status. Buyers still need to confirm that this marking aligns with their own jurisdiction’s requirements and the intended clinical or surveillance use.

The kit is intended for trained personnel following instructions for use, laboratory procedures, and local regulatory requirements. That makes documentation, training, and compatibility with existing PCR instruments and extraction workflows central checks.

Scientific China lists sourcing, configuration, MOQ, and logistics support. For procurement teams, the practical questions are package size, minimum order quantity, delivery options, and a formal quotation.

Because the listing does not specify instrument compatibility, assay targets, sensitivity, or shelf life, those details should be requested directly from the supplier before purchase.

The value of a kit like this depends less on the label than on whether it fits validated lab workflows and regulatory clearances. Verification should come before commitment.

Why it matters:
CE-IVD status and test count are not enough on their own. Confirm jurisdiction, instrument compatibility, and documentation before ordering.

View Product →